60.23 USD
+1.81 (+3.1%)
60.34 USD
+0.11 (+0.18%)
We assign a fundamental rating of 7 out of 10 to DXCM. DXCM was compared to 188 industry peers in the Health Care Equipment & Supplies industry. DXCM gets an excellent profitability rating and is at the same time showing great financial health properties. DXCM is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings could make DXCM a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
In the past year DXCM was profitable.
In the past year DXCM had a positive cash flow from operations.
DXCM had positive earnings in each of the past 5 years.
Each year in the past 5 years DXCM had a positive operating cash flow.
1.2 Ratios
DXCM's Return On Assets of 9.61% is amongst the best of the industry. DXCM outperforms 92.02% of its industry peers.
DXCM has a Return On Equity of 26.44%. This is amongst the best in the industry. DXCM outperforms 96.28% of its industry peers.
DXCM has a better Return On Invested Capital (15.72%) than 95.21% of its industry peers.
DXCM had an Average Return On Invested Capital over the past 3 years of 11.25%. This is above the industry average of 8.98%.
The 3 year average ROIC (11.25%) for DXCM is below the current ROIC(15.72%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.61% | ||
| ROE | 26.44% | ||
| ROIC | 15.72% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
1.3 Margins
DXCM has a better Profit Margin (15.96%) than 92.02% of its industry peers.
DXCM's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 18.41%, DXCM belongs to the top of the industry, outperforming 89.36% of the companies in the same industry.
DXCM's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 60.20%, DXCM is in the better half of the industry, outperforming 60.11% of the companies in the same industry.
In the last couple of years the Gross Margin of DXCM has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.41% | ||
| PM (TTM) | 15.96% | ||
| GM | 60.2% |
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), DXCM is creating value.
The number of shares outstanding for DXCM has been increased compared to 1 year ago.
The number of shares outstanding for DXCM has been increased compared to 5 years ago.
Compared to 1 year ago, DXCM has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 4.55 indicates that DXCM is not in any danger for bankruptcy at the moment.
DXCM's Altman-Z score of 4.55 is fine compared to the rest of the industry. DXCM outperforms 77.13% of its industry peers.
The Debt to FCF ratio of DXCM is 2.36, which is a good value as it means it would take DXCM, 2.36 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.36, DXCM belongs to the top of the industry, outperforming 86.70% of the companies in the same industry.
A Debt/Equity ratio of 0.47 indicates that DXCM is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.47, DXCM perfoms like the industry average, outperforming 44.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 2.36 | ||
| Altman-Z | 4.55 |
ROIC/WACC1.99
WACC7.9%
2.3 Liquidity
DXCM has a Current Ratio of 1.56. This is a normal value and indicates that DXCM is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of DXCM (1.56) is worse than 72.87% of its industry peers.
A Quick Ratio of 1.38 indicates that DXCM should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.38, DXCM is not doing good in the industry: 62.23% of the companies in the same industry are doing better.
DXCM does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
DXCM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.41%, which is quite good.
Measured over the past years, DXCM shows a very strong growth in Earnings Per Share. The EPS has been growing by 29.25% on average per year.
DXCM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.21%.
Measured over the past years, DXCM shows a very strong growth in Revenue. The Revenue has been growing by 22.27% on average per year.
EPS 1Y (TTM)9.41%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%35.56%
Revenue 1Y (TTM)14.21%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%21.64%
3.2 Future
The Earnings Per Share is expected to grow by 22.40% on average over the next years. This is a very strong growth
DXCM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.43% yearly.
EPS Next Y27.59%
EPS Next 2Y24.04%
EPS Next 3Y22.49%
EPS Next 5Y22.4%
Revenue Next Year15.4%
Revenue Next 2Y14.3%
Revenue Next 3Y13.94%
Revenue Next 5Y13.43%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 32.38, DXCM can be considered very expensive at the moment.
Based on the Price/Earnings ratio, DXCM is valued a bit cheaper than 72.87% of the companies in the same industry.
DXCM's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 25.45.
With a Price/Forward Earnings ratio of 23.72, DXCM is valued on the expensive side.
Based on the Price/Forward Earnings ratio, DXCM is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
DXCM's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 34.46.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.38 | ||
| Fwd PE | 23.72 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DXCM is valued a bit cheaper than 75.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, DXCM is valued cheaper than 84.04% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.24 | ||
| EV/EBITDA | 19.15 |
4.3 Compensation for Growth
DXCM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of DXCM may justify a higher PE ratio.
A more expensive valuation may be justified as DXCM's earnings are expected to grow with 22.49% in the coming years.
PEG (NY)1.17
PEG (5Y)1.11
EPS Next 2Y24.04%
EPS Next 3Y22.49%
5. Dividend
5.1 Amount
DXCM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
60.23
+1.81 (+3.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners97.73%
Inst Owner Change19.83%
Ins Owners0.19%
Ins Owner Change3.36%
Market Cap23.62B
Revenue(TTM)4.52B
Net Income(TTM)720.70M
Analysts85
Price Target102.13 (69.57%)
Short Float %2.86%
Short Ratio1.64
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.05%
Min EPS beat(2)5.32%
Max EPS beat(2)6.77%
EPS beat(4)2
Avg EPS beat(4)-0.91%
Min EPS beat(4)-11.66%
Max EPS beat(4)6.77%
EPS beat(8)6
Avg EPS beat(8)4.61%
EPS beat(12)10
Avg EPS beat(12)13.69%
EPS beat(16)11
Avg EPS beat(16)6.53%
Revenue beat(2)2
Avg Revenue beat(2)0.74%
Min Revenue beat(2)0.61%
Max Revenue beat(2)0.88%
Revenue beat(4)2
Avg Revenue beat(4)0.02%
Min Revenue beat(4)-1.2%
Max Revenue beat(4)0.88%
Revenue beat(8)2
Avg Revenue beat(8)-0.92%
Revenue beat(12)5
Avg Revenue beat(12)-0.38%
Revenue beat(16)6
Avg Revenue beat(16)-0.58%
PT rev (1m)-2.27%
PT rev (3m)-3.18%
EPS NQ rev (1m)-4.53%
EPS NQ rev (3m)-4.87%
EPS NY rev (1m)0.59%
EPS NY rev (3m)1.67%
Revenue NQ rev (1m)-1.01%
Revenue NQ rev (3m)-0.94%
Revenue NY rev (1m)0.36%
Revenue NY rev (3m)0.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.38 | ||
| Fwd PE | 23.72 | ||
| P/S | 5.23 | ||
| P/FCF | 22.24 | ||
| P/OCF | 16.31 | ||
| P/B | 8.66 | ||
| P/tB | 9 | ||
| EV/EBITDA | 19.15 |
EPS(TTM)1.86
EY3.09%
EPS(NY)2.54
Fwd EY4.22%
FCF(TTM)2.71
FCFY4.5%
OCF(TTM)3.69
OCFY6.13%
SpS11.52
BVpS6.95
TBVpS6.69
PEG (NY)1.17
PEG (5Y)1.11
Graham Number17.06
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.61% | ||
| ROE | 26.44% | ||
| ROCE | 19.96% | ||
| ROIC | 15.72% | ||
| ROICexc | 77.75% | ||
| ROICexgc | 88.6% | ||
| OM | 18.41% | ||
| PM (TTM) | 15.96% | ||
| GM | 60.2% | ||
| FCFM | 23.51% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
ROICexc(3y)35.45%
ROICexc(5y)29.66%
ROICexgc(3y)40.94%
ROICexgc(5y)33.19%
ROCE(3y)14.28%
ROCE(5y)11.73%
ROICexgc growth 3Y55.18%
ROICexgc growth 5Y18.96%
ROICexc growth 3Y50.14%
ROICexc growth 5Y16.58%
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
F-Score5
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 2.36 | ||
| Debt/EBITDA | 1.2 | ||
| Cap/Depr | 158.02% | ||
| Cap/Sales | 8.55% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 134.63% | ||
| Profit Quality | 147.34% | ||
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 4.55 |
F-Score5
WACC7.9%
ROIC/WACC1.99
Cap/Depr(3y)175.34%
Cap/Depr(5y)240.83%
Cap/Sales(3y)9.32%
Cap/Sales(5y)10.84%
Profit Quality(3y)97.76%
Profit Quality(5y)73.64%
High Growth Momentum
Growth
EPS 1Y (TTM)9.41%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%35.56%
EPS Next Y27.59%
EPS Next 2Y24.04%
EPS Next 3Y22.49%
EPS Next 5Y22.4%
Revenue 1Y (TTM)14.21%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%21.64%
Revenue Next Year15.4%
Revenue Next 2Y14.3%
Revenue Next 3Y13.94%
Revenue Next 5Y13.43%
EBIT growth 1Y28.95%
EBIT growth 3Y30.52%
EBIT growth 5Y33.11%
EBIT Next Year77.25%
EBIT Next 3Y38.83%
EBIT Next 5Y31.12%
FCF growth 1Y112.47%
FCF growth 3Y127.88%
FCF growth 5Y36.21%
OCF growth 1Y93.75%
OCF growth 3Y30.77%
OCF growth 5Y25.76%
DEXCOM INC / DXCM FAQ
Can you provide the ChartMill fundamental rating for DEXCOM INC?
ChartMill assigns a fundamental rating of 7 / 10 to DXCM.
What is the valuation status for DXCM stock?
ChartMill assigns a valuation rating of 6 / 10 to DEXCOM INC (DXCM). This can be considered as Fairly Valued.
Can you provide the profitability details for DEXCOM INC?
DEXCOM INC (DXCM) has a profitability rating of 9 / 10.
What are the PE and PB ratios of DEXCOM INC (DXCM) stock?
The Price/Earnings (PE) ratio for DEXCOM INC (DXCM) is 32.38 and the Price/Book (PB) ratio is 8.66.